Cargando…
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
INTRODUCTION: Clinical trials in Alzheimer's disease are aimed at early stages of disease, including preclinical Alzheimer's disease. The high cost and time required to screen large numbers of participants for Aβ pathology impede the development of novel drugs. This study's objective...
Autores principales: | Insel, Philip S., Palmqvist, Sebastian, Mackin, R. Scott, Nosheny, Rachel L., Hansson, Oskar, Weiner, Michael W., Mattsson, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045949/ https://www.ncbi.nlm.nih.gov/pubmed/27722193 http://dx.doi.org/10.1016/j.dadm.2016.07.002 |
Ejemplares similares
-
Predicting amyloid status using self‐report information from an online research and recruitment registry: The Brain Health Registry
por: Ashford, Miriam T., et al.
Publicado: (2020) -
Machine learning approaches to predicting amyloid status using data from an online research and recruitment registry: The Brain Health Registry
por: Albright, Jack, et al.
Publicado: (2021) -
Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry
por: Mackin, R. Scott, et al.
Publicado: (2018) -
Evidence for age-associated cognitive decline from Internet game scores
por: Geyer, Jason, et al.
Publicado: (2015) -
Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)